Press Releases

ATLANTA, March 26, 2020 /PRNewswire/ -- VERO Biotech LLC, an Atlanta, Georgia-based biotechnology company focused on saving lives, alleviating suffering, and improving the health economics of care, today announced that the U.S. Food and Drug Administration (FDA) has granted "expanded access emergency use" allowing its proprie

MCKINNEY, Texas, March 26, 2020 /PRNewswire/ -- MyTelemedicine announced the release of its Rapid Response Virtual Care Platform. This rollout brings expanded capabilities to their already robust telehealth platform, giving doctors, group practices, and hospital systems the ability to consult virtually with their patients. MyTelemedicine's virtual care platform can

FOSTER CITY, Calif., March 26, 2020 /PRNewswire/ -- SutroVax, a biopharmaceutical company dedicated to the delivery of superior and novel vaccines designed to prevent or treat some of the most comm

GUILFORD, Conn., March 26, 2020 /PRNewswire/ -- Butterfly Network, the company helping to transform healthcare with its disruptive, ultrasound-on-chip™ technology, has named Laurent Faracci as CEO.

SAN DIEGO, March 26, 2020 /PRNewswire/ -- Seqster, the award-winning SaaS-based technology platform enabling person-centric health data management, today announced the release of our

SAN CARLOS, Calif., March 26, 2020 /PRNewswire/ -- Apexigen, Inc., a clinical-stage biopharmaceutical company, today announced that Xiaodong Yang, M.D., Ph.D., President and Chief Executive Officer, plans to present an overview of the company at the upcoming Solebury Trout Virtual Investor Conference. The 25-minute presentation includ

OKLAHOMA CITY, March 26, 2020 /PRNewswire/ -- Stability Cannabis announces that it has committed $20,000 to Oklahoma based nonprofit groups in 2020 through the newly created Stability Gives program.

HERTFORDSHIRE, England and PITTSBURGH and NEW YORK, March 26, 2020 /PRNewswire/ -- Mylan N.V. (Nasdaq: MYL) and Pfizer Inc. (NYSE: PFE) today announced that due to the unprecedented circumstances surrounding the COVID-19 pandemic, including associated delays in the regulatory review process, the proposed

ZURICH, March 26, 2020 /PRNewswire/ -- RELIEF THERAPEUTICS Holding AG (SIX: RLF) "Relief", together with NeuroRx, a Delaware Corporation, have filed an Investigational New Drug (IND) Application with the US FDA for a phase 2 trial of RLF-100 (Aviptadil) in the treatment of Acute and Moderate Respiratory Distress in patients infected by the COVID-19 coronavir

SHANGHAI, March 26, 2020 /PRNewswire/ -- CStone Pharmaceuticals ("CStone"; HKEX: 2616), a leading biopharmaceutical company focused on developing and commercializing innovative immuno-oncology (IO) therapies and molecularly-targeted precision medicines for the treatment of cancer, today released its audited annual financial results for the year ended